Washington University School of Medicine: Immunotherapy Blocks Scarring, Improves Heart Function in Mice With Heart Failure
October 24, 2024
October 24, 2024
ST. LOUIS, Missouri, Oct. 24 (TNSres) -- The Washington University School of Medicine issued the following news release:
* * *
Antibody that reduces inflammation could serve as cardio-immunotherapy for heart failure patients
* * *
A new study from Washington University School of Medicine in St. Louis suggests that a type of immunotherapy -- similar to that approved by the Food and Drug Administration (FDA) to treat inflammatory conditions such . . .
* * *
Antibody that reduces inflammation could serve as cardio-immunotherapy for heart failure patients
* * *
A new study from Washington University School of Medicine in St. Louis suggests that a type of immunotherapy -- similar to that approved by the Food and Drug Administration (FDA) to treat inflammatory conditions such . . .